Literature DB >> 8095979

Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study.

J K Wu1, R D Folkerth, Z Ye, B T Darras.   

Abstract

Oligodendrogliomas are indolent brain tumors with mean postoperative survival of about 5 years. However, the range of postoperative survivals is wide, suggesting that these tumors are heterogeneous in their biologic behavior. Using restriction fragment length polymorphism (RFLP) analysis, we studied a case of an oligodendroglioma with loss of chromosome 10 sequences, a finding that has only been reported in glioblastoma multiforme and anaplastic astrocytomas. Four and a half months after the initial surgery the patient returned with a recurrent tumor having classic radiologic and pathologic features of glioblastoma multiforme. Loss of chromosome 10 alleles in oligodendroglioma may be predictive of aggressive biologic behavior, even in the absence of recognized histopathologic characteristics of anaplasia, and may enable us to select more appropriate treatments for this group of patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095979     DOI: 10.1007/bf01050260

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

Authors:  R A Weinberg
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

2.  Oligodendroglioma. A comparison of two grading systems.

Authors:  J M Kros; D Troost; C G van Eden; A J van der Werf; H B Uylings
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

3.  Postoperative survival of patients with intracranial oligodendroglioma with special reference to radical tumor removal; a study of 26 patients.

Authors:  G HORRAX; W Q WU
Journal:  J Neurosurg       Date:  1951-09       Impact factor: 5.115

Review 4.  Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms.

Authors:  K K Kidd; A M Bowcock; J Schmidtke; R K Track; F Ricciuti; G Hutchings; A Bale; P Pearson; H F Willard; J Gelernter
Journal:  Cytogenet Cell Genet       Date:  1989

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors:  M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

7.  A clinicopathological study of 323 patients with oligodendrogliomas.

Authors:  C L Ludwig; M T Smith; A D Godfrey; V W Armbrustmacher
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

8.  Oligodendroglioma. Histologic evaluation and prognosis.

Authors:  S J Mørk; T B Halvorsen; K F Lindegaard; G E Eide
Journal:  J Neuropathol Exp Neurol       Date:  1986-01       Impact factor: 3.685

9.  Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

Authors:  H W Chin; J J Hazel; T H Kim; J H Webster
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

10.  Oligodendroglioma. An analysis of the value of radiation therapy.

Authors:  D E Bullard; C E Rawlings; B Phillips; E B Cox; S C Schold; P Burger; E C Halperin
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

View more
  1 in total

1.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.

Authors:  J Reifenberger; G Reifenberger; L Liu; C D James; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.